Google is set to launch its first test satellite for an in-space AI data center. It’s set to lift off aboard a SpaceX Falcon ...
Ruby Igwe, Regional Director, West & Central Africa at ALX, argued that as young Africans continue to build digital skills, ...
ALX, a pan-African talent accelerator has called for greater alignment between skills providers, employers, governments and ...
When Esther Owusu Nkwantabisah needed a display fridge for her fledgling food business, buying one was not an option. So she improvised.
Hyper Light Drifter developer Heart Machine appears to be on life support following a recent setback with a publisher. The publisher pulled out of Heart Machine's project, which leaves the team with ...
Australian companies have attracted a wave of takeover interest from private equity firms and overseas investors so far in 2026, although only a limited number of those approaches have advanced beyond ...
Globe Magazine kicks off the 2026 Hispanic Heritage Month (September 15-October 15) by publishing this list of 100 leaders working across Massachusetts, selected by We Are ALX, a nonpartisan, ...
This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. The U.S. is abandoning its failed strategy of solely controlling physical chip exports to ...
Update on Phase III trial of Ultomiris in adults and adolescents with thrombotic microangiopathy after haematopoietic stem cell transplant High-level results from the ALXN1210-TMA-313 Phase III ...
This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Data centers, once unseen infrastructure, are now being built everywhere. The brief ...
SOUTH SAN FRANCISCO, Calif., June 30, 2026 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc. ("ALX Oncology," Nasdaq: ALXO), a clinical-stage biotechnology company advancing a pipeline of novel therapies ...
MORRISVILLE, N.C.--(BUSINESS WIRE)--Vast Therapeutics, a clinical-stage life science company developing nitric oxide-based medicines for serious lung diseases, today announced late-breaking Phase 1 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results